Symposia: Acute Myeloid Leukemias: Clinical and Epidemiological
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Acute Myeloid Malignancies, AML, adult, epidemiology, Clinical Practice (Health Services and Quality), Non-Biological therapies, Clinical Research, health outcomes research, Combination therapy, Chemotherapy, Diseases, Therapies, real-world evidence, Myeloid Malignancies, Study Population, Human, Minimal Residual Disease
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Acute Myeloid Malignancies, AML, adult, epidemiology, Clinical Practice (Health Services and Quality), Non-Biological therapies, Clinical Research, health outcomes research, Combination therapy, Chemotherapy, Diseases, Therapies, real-world evidence, Myeloid Malignancies, Study Population, Human, Minimal Residual Disease
Saturday, December 10, 2022: 9:30 AM-11:00 AM
208-210
(Ernest N. Morial Convention Center)
Moderators:
Guru Subramanian Guru Murthy, MBBS, Medical College of Wisconsin
and
Gina Keiffer, MD, Thomas Jefferson University
Disclosures:
No relevant conflicts of interest to declare.
This session includes studies that examine innovations in prognostication, risk factor analysis, and clinical trial design for patients with acute myeloid leukemia.
9:30 AM
9:45 AM
10:15 AM
10:30 AM
10:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH